Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Current Liabilities (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Total Current Liabilities for 6 consecutive years, with $108.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 98.68% to $108.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $108.9 million, a 98.68% increase, with the full-year FY2025 number at $108.9 million, up 98.68% from a year prior.
  • Total Current Liabilities was $108.9 million for Q4 2025 at GeneDx Holdings, up from $87.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $204.6 million in Q2 2022 to a low of $50.7 million in Q1 2024.
  • A 5-year average of $92.3 million and a median of $75.0 million in 2021 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 161372.03% in 2021, then tumbled 59.24% in 2023.
  • GeneDx Holdings' Total Current Liabilities stood at $101.3 million in 2021, then surged by 42.47% to $144.3 million in 2022, then crashed by 59.24% to $58.8 million in 2023, then dropped by 6.8% to $54.8 million in 2024, then soared by 98.68% to $108.9 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Total Current Liabilities are $108.9 million (Q4 2025), $87.6 million (Q3 2025), and $71.4 million (Q2 2025).